Formats:
- Our 100 assay point kit allows you to run 100 wells in 96-well format, using a 100 µL reaction volume (10 µL of sample).
- Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
- Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
Features:
- No-wash steps, no separation steps
- ELISA alternative technology
- Sensitive detection
- Broad sample compatibility
- Small sample volume
- Results in less than 3 hours
- Half the time of an ELISA assay
AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.
Human FMS Related Tyrosine Kinase 1 (FLT1) also known as Vascular Endothelial Growth Factor Receptor 1 is a receptor tyrosine kinase involved in the regulation of angiogenesis and vasculogensis. FLT1 plays a roles in cell migration, as well as promotes cell proliferation. It spans the cell membrane with a cytoplasmic transmembrane domain and an extracellular ligand binding region. With its role in cell proliferation, FLT1 is studied for its effect on cancer and tumor growth, specifically its link to metastasis.